Form 8-K - Current report:
SEC Accession No. 0001193125-24-258694
Filing Date
2024-11-14
Accepted
2024-11-14 16:37:30
Documents
15
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d879713d8k.htm   iXBRL 8-K 26286
2 EX-99.1 d879713dex991.htm EX-99.1 83430
6 GRAPHIC g879713g1113075015560.jpg GRAPHIC 2631
  Complete submission text file 0001193125-24-258694.txt   243976

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bntc-20241114.xsd EX-101.SCH 2887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20241114_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20241114_pre.xml EX-101.PRE 10837
17 EXTRACTED XBRL INSTANCE DOCUMENT d879713d8k_htm.xml XML 3485
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 241463464
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)